Youcare Pharmaceutical Group Co., Ltd. (688658.SS)
CNY 18.35
(-2.18%)
CNY 18.35
(-2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.19 Billion | 4.54 Billion | 4.96 Billion | 4.33 Billion | 4.28 Billion | 3.98 Billion |
| Cost of Revenue | 1.62 Billion | 1.6 Billion | 1.52 Billion | 1.47 Billion | 1.67 Billion | 1.58 Billion |
| Gross Profit | 2.57 Billion | 2.93 Billion | 3.43 Billion | 2.86 Billion | 2.61 Billion | 2.39 Billion |
| Operating Expenses | 2.39 Billion | 2.51 Billion | 2.77 Billion | 2.31 Billion | 2.21 Billion | 2.01 Billion |
| Selling, General and Administrative Expenses | 1.82 Billion | 2.05 Billion | 2.39 Billion | 2.05 Billion | 1.92 Billion | 1.75 Billion |
| Research and Development Expenses | 351.87 Million | 344.41 Million | 200.03 Million | 127.89 Million | 126.18 Million | 98.1 Million |
| Other Expenses | 216.43 Million | 121.47 Million | 178.89 Million | 128.64 Million | 170.91 Million | 1.45 Million |
| Cost and Expenses | 3.96 Billion | 4.12 Billion | 4.3 Billion | 3.78 Billion | 3.89 Billion | 3.6 Billion |
| Operating Income | 231.75 Million | 357.94 Million | 636.82 Million | 492.15 Million | 328.05 Million | 323.41 Million |
| Interest Expense | 14.45 Million | 4.69 Million | 3.47 Million | 25.06 Million | 36.41 Million | 40.93 Million |
| Income Tax Expense | 35.77 Million | 10.78 Million | 85.54 Million | 51.5 Million | 43.97 Million | 55.96 Million |
| Earnings before Tax | 223.26 Million | 349.52 Million | 629.27 Million | 495.13 Million | 331.76 Million | 324.86 Million |
| Net Income | 184.79 Million | 335.18 Million | 545.31 Million | 442.13 Million | 285.45 Million | 267.94 Million |
| Earnings Per Share Basic | 0.41 | 0.74 | 1.21 | 0.98 | 0.63 | 0.74 |
| Earnings Per Share Diluted | 0.41 | 0.74 | 1.21 | 0.98 | 0.63 | 0.74 |
| Weighted Average Shares Outstanding | 450.72 Million | 450 Million | 450 Million | 450 Million | 450 Million | 361.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 450.72 Million | 450 Million | 450 Million | 450 Million | 450 Million | 361.33 Million |
| Gross Margin | 0.61 | 0.65 | 0.69 | 0.66 | 0.61 | 0.60 |
| EBIT Margin | 0.10 | 0.14 | 0.17 | 0.15 | 0.10 | 0.11 |
| Profit Margin | 0.04 | 0.07 | 0.11 | 0.10 | 0.07 | 0.07 |
| EBITDA | 418.36 Million | 521.07 Million | 775.43 Million | 657.94 Million | 499.92 Million | 485.73 Million |
| Earnings Before Tax Margin | 0.06 | 0.08 | 0.13 | 0.11 | 0.08 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Billion | 969.32 Million | 967.9 Million | 4.19 Billion | 1.23 Billion | 757.78 Million |
| Cost of Revenue | 372.31 Million | 379.77 Million | 455.91 Million | 1.56 Billion | 511.46 Million | 315.7 Million |
| Gross Profit | 655.57 Million | 589.55 Million | 511.98 Million | 2.63 Billion | 727.73 Million | 442.08 Million |
| Operating Expenses | 552.89 Million | 529.71 Million | 441.9 Million | 3.96 Billion | 1.17 Billion | 495.67 Million |
| Selling, General and Administrative Expenses | 455.65 Million | 424.17 Million | 351.46 Million | - | 359.39 Million | 463.09 Million |
| Research and Development Expenses | 83.51 Million | 78.76 Million | 85.49 Million | - | 120.15 Million | 92.54 Million |
| Other Expenses | -13.72 Million | -26.78 Million | -1.24 Million | -3.96 Billion | -1.17 Billion | -1 Million |
| Cost and Expenses | 925.21 Million | 909.48 Million | 897.82 Million | 3.96 Billion | 1.17 Billion | 811.37 Million |
| Operating Income | 102.67 Million | 59.83 Million | 80.36 Million | 234.33 Million | 61.86 Million | -62.38 Million |
| Interest Expense | 5.76 Million | 5.88 Million | 5.53 Million | 13.21 Million | 4.2 Million | 3.33 Million |
| Income Tax Expense | 19.47 Million | 10.6 Million | 9.99 Million | 37.58 Million | 26.45 Million | -9.38 Million |
| Earnings before Tax | 109.73 Million | 59.42 Million | 79.11 Million | 225.84 Million | 60.08 Million | -63.39 Million |
| Net Income | 91.17 Million | 49.24 Million | 69.3 Million | 184.79 Million | 32.52 Million | -54.8 Million |
| Earnings Per Share Basic | 0.21 | 0.11 | 0.15 | - | 0.08 | -0.12 |
| Earnings Per Share Diluted | 0.21 | 0.11 | 0.15 | - | 0.08 | -0.12 |
| Weighted Average Shares Outstanding | 444.48 Million | 444.48 Million | 462.03 Million | 450.72 Million | 449.32 Million | 450 Million |
| Weighted Average Shares Outstanding (Diluted) | 444.48 Million | 444.48 Million | 462.03 Million | 450.72 Million | 449.32 Million | 450 Million |
| Gross Margin | 0.64 | 0.61 | 0.53 | 0.63 | 0.59 | 0.58 |
| EBIT Margin | 0.11 | 0.12 | 0.08 | - | 0.08 | -0.07 |
| Profit Margin | 0.09 | 0.05 | 0.07 | 0.04 | 0.03 | -0.07 |
| EBITDA | 115.49 Million | 112.37 Million | 74.89 Million | - | 98.68 Million | -50.86 Million |
| Earnings Before Tax Margin | 0.10 | 0.06 | 0.08 | 0.06 | 0.05 | -0.08 |
TGHLF
BANCOINDIA
2469
DEEPAKCHEM
AKRIT
POPULARES